🤔Have you explored the FIBROTARGET Training academy? Learn about: ✅Experimental methods to study intestinal fibrosis ✅In-vivo models for fibrosis induction ✅omics-based techniques 💻Explore the full Training Academy on the FIBROTARGET web➡️: https://loom.ly/wj313Io #HorizonEurope #IBD

💬For Cora Sanches, living with ulcerative colitis has become a starting point for advocacy. In this patient story, the young IFCCA patient advocate from Brazil shares how her personal experience has grown into a commitment to support and empower others. 🎥https://loom.ly/LfDrB7Y

FIBROTARGET Patient Stories: Cora

FIBROTARGET

youtube.com

📹 How can we improve outcomes for people living with IBD? In this interview, FIBROTARGET coordinator Gianluca Matteoli discusses earlier diagnosis, better monitoring and the importance of patient involvement. 📹 Watch the full interview & learn more about FIBROTARGET➡️ https://loom.ly/OljVKGY

🔍 What is intestinal fibrosis, and why is it such a major challenge for people living with IBD? Our FIBROTARGET factsheet provides an accessible overview of the condition and the project's work to improve its diagnosis, monitoring and treatment Learn more here➡️ https://loom.ly/1kbh0bc

🎓The FIBROTARGET Training Academy is now fully available, with all modules online! Explore practical training resources covering in vitro, in vivo and ex vivo fibrosis models, as well as omics-based annotation. 📚 🔗 Discover the full Academy and start learning: https://loom.ly/wj313Io

🎥 ICYMI: How does IBD shape life beyond the diagnosis? Noemi Stefanucci, a young IBD advocate from Italy and member of the IFCCA Youth Group, shares her experience of living with Crohn's disease and the impact it has had on her life. Learn more➡️https://loom.ly/yJfqEyE #IBD #DiseaseAwareness

📚 Explore FIBROTARGET's growing collection of scientific publications on intestinal fibrosis and fibrostenosis in IBD. 💻Browse the research and read accompanying explainers on our website. https://loom.ly/Y58Ax5s

📚 The full FIBROTARGET #TrainingAcademy is now available! Explore 4 expert-led modules covering in vitro, in vivo and ex vivo fibrosis models, plus omics-based annotation for studying intestinal fibrosis in IBD. 💻 Learn more: https://loom.ly/wj313Io

📚 New: the FIBROTARGET Training Academy – a resource to learn more about intestinal fibrosis in IBD. 3 modules now live, covering key concepts, challenges, and emerging research directions. 💻 Start exploring here: https://loom.ly/wj313Io

🔊This week! FIBROTARGET joins the GENEGUT Cluster Event on RNA therapeutics for IBD (24 June), alongside EU projects, researchers, industry and patient groups to discuss key challenges and strengthen collaboration. Explore the VR exhibition here➡️https://loom.ly/XRPsM #HorizonEurope

📸 FIBROTARGET is LIVE at #ECM2026 in Copenhagen! Coordinator Gianluca Matteoli and Bram Verstockt (KU Leuven) are presenting ongoing work in intestinal fibrosis and engaging with the ECM research community. Learn more about the FIBROTARGET project here➡️https://loom.ly/IGYRLgM

📚Discover the FIBROTARGET Training Academy: a new resource designed to support learning on intestinal fibrosis in IBD! Three modules are now available, offering insights into key concepts, current challenges, and emerging approaches in fibrosis research. 💻Learn more: https://loom.ly/wj313Io

📹 Why does intestinal fibrosis remain such a major unmet need in IBD? On 3 June, FIBROTARGET’s Bram Verstockt joins the Nordic Bioscience webinar on collagen remodelling and fibrosis looking at current challenges and new clinical insights. Register here➡️ https://loom.ly/na2rE6A

📣 This #WorldIBDDay2026, FIBROTARGET supported the global campaign on access to IBD care, highlighting ongoing gaps in diagnosis, treatment and support. ➡️ Explore FIBROTARGET's contribution here: https://loom.ly/Y5rDUNA #WorldIBDDay2026 #IBDHasNoBorders #HorizonEU

🟣🗺️ Today is #WorldIBDDay IBD Has No Borders. Access to care should not depend on geography. We support IFCCA’s call for equitable, timely IBD care worldwide and highlight the need to prevent complications like fibrosis. Learn more➡️: https://loom.ly/cVlk6EQ #IBDHasNoBorders

#WorldIBDDay highlights the need for timely, equitable care. Early diagnosis in #IBD remains a challenge, affecting progression and outcomes. FIBROTARGET coordinator Gianluca Matteoli explains how research supports earlier detection, better tools and patient involvement. 📹 Watch the interview ⤵️

🔍Looking inside the gut: imaging tools to understand IBD fibrosis 🔬New non‑invasive imaging approaches aim to strengthen how fibrosis is detected, helping clinicians make clearer, more consistent decisions. ➡️Learn more and read the full article here: https://loom.ly/Qxk3wL4 #IBDHasNoBorders

📌 ICYMI: FIBROTARGET has released Training Academy – Module 2, focusing on in vivo fibrosis models for IBD research. Practical insights for early‑career researchers working on intestinal fibrosis 🔬 Explore the Training Academy here ➡️ https://loom.ly/wj313Io

📢Early detection should not be a privilege. ➡️In IBD, specific biomarkers have been identified that can support diagnosis and classification, help monitor disease activity, and inform the likelihood of responding to treatment. 👉Learn more: https://loom.ly/Whlbs78 #AccessToCare #IBDHasNoBorders

Biomarkers in IBD Fibrosis: Explained

Biomarkers are molecules found within the body that can signal the presence, progression, or severity of a disease or condition. Biomarkers associated with IBD Fibrosis could improve standard of care for patients through early detection and better disease monitoring.

fibrotarget.eu

🎥 New reel out now! Highlights from the FIBROTARGET GAM 2026 in Barcelona: two days of scientific exchange, multistakeholder perspectives and collaboration. Hear from coordinator Gianluca Matteoli and clinical lead Bram Verstockt for more on progress. Key takeaways➡️ https://loom.ly/VX7K4iU

🚫 Fibrosis is not the same as inflammation, and once it has progressed, it often cannot be reversed. When IBD care is delayed, the risk of fibrosis and surgery increases. ➡️Understanding fibrosis supports earlier, more equitable care. Discover more!⬇️ #WorldIBDDay2026 #IBDHasNoBorders

🗺️ #WorldIBDDay2026 (19 May) reminds us: access to IBD care should not depend on geography. In the lead‑up, #FIBROTARGET will focus on intestinal fibrosis - a complication often linked to delayed diagnosis and gaps in care. Discover more➡️https://fibrotarget.eu/ #IBDHasNoBorders #AccessToIBDCare

🔬🤝From Clinical Trials to Real Impact: Turning Fibrosis Research into Better Care FIBROTARGET and IFCCA recently hosted a webinar bringing together researchers, clinicians, industry and patient voices to discuss the future of fibrosis care in IBD! 📺Watch the recording: https://loom.ly/z0gezTw

🎓New training resource released: FIBROTARGET Training Academy – Module 2 This new module focuses on in vivo fibrosis models, supporting early‑career researchers working in IBD with practical training on fibrosis induction and monitoring in mice🔬. Discover the Academy!➡️ https://loom.ly/wj313Io

📣 Webinar today - don’t miss it! Join the FIBROTARGET–IFCCA webinar to explore how fibrosis research and patient voices can lead to real improvements in IBD care. 🗓️ Today | 2 April 2026 🕕 18:00–19:00 CEST | 🌐 Online Register now: https://loom.ly/RuUAO_M #IBD #Fibrosis #PatientVoice

📣 This week: FIBROTARGET–IFCCA webinar Living with IBD fibrosis? Join this free online webinar to explore how research and patient voices can lead to real improvements in care and quality of life. 📆 2 Apr • 🌐 Online Register➡️: https://loom.ly/RuUAO_M #IBD #Fibrosis #PatientVoice

🎥In this patient story, Noemi Stefanucci, a young IBD advocate from Italy and member of the IFCCA Youth Group, looks back on how the condition has shaped her life, decisions and career path. Learn more➡️https://loom.ly/yJfqEyE #IBD #DiseaseAwareness

⏳ One week to go! How can fibrosis research improve daily life for people living with IBD? Join the FIBROTARGET–IFCCA webinar to explore how patient needs and lived experience can shape better trials and future care. 📆 2 Apr • 🌐 Online • 🕕 18:00–19:00 CEST 👉 Register: https://loom.ly/Qlznsec

🌐Wrapping up the FIBROTARGET GAM 2026! Two days in Barcelona brought partners together to review progress, share insights and align on next steps. Highlights included fibrosis research, patient perspectives, imaging advances and collaboration workshops. ➡️More: https://loom.ly/VX7K4iU

FIBROTARGET Advances IBD Fibrosis Research: updates from 4th GAM

On 19–20 March 2026, the FIBROTARGET consortium convened in Barcelona for its 4th face‑to‑face General Assembly Meeting (GAM#4). Hosted by Teamit the two‑day meeting brought partners together to review scientific progress, discuss operational and regulatory developments across FIBROTARGET, and align on priorities for the next phase of the project. 

fibrotarget.eu

🌍👥 FIBROTARGET GAM 2026 is underway in Barcelona! FIBROTARGET partners have gathered in Barcelona for our 4th GAM to present latest updates, discuss current challenges and outline future directions for the project. Stay tuned for more updates soon! 🔗 https://loom.ly/IGYRLgM